Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol

International Journal of Biological Macromolecules

Volumn 65, Issue , 2014, Pages 346-356

  Dey, Sanjay ^a,b   Mazumder, Bhaskar ^a   Chattopadhyay, Sankha ^c   Das, Malay Kanti ^c   Sinha, Samarendu ^c   Ganguly, Shantanu ^c   De, Kakali ^d   Mishra, Mridula ^d  

^a DIBRUGARH UNIVERSITY   (India)

^b Durgapur 713212   (India)

^c VARIABLE ENERGY CYCLOTRON CENTRE   (India)

^d INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Atenolol; Floating matrix tablet; Guar gum; Optimization; Xanthan gum

Indexed keywords

ATENOLOL; BICARBONATE; CARBON DIOXIDE; CITRIC ACID; GUAR GUM; NICLOSAMIDE; XANTHAN; BIOPOLYMER; DELAYED RELEASE FORMULATION; TABLET;

ANIMAL EXPERIMENT; ARTICLE; CURVE FITTING; DIFFUSION EXPONENT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTENT; DRUG DOSAGE FORM COMPARISON; DRUG RETENTION; DRUG SCREENING; DRUG STABILITY; FACTORIAL DESIGN; FEMALE; FIRST PASS EFFECT; FLOATING TIME; GUAR; IN VITRO STUDY; IN VIVO STUDY; MALE; MATRIX TABLET; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PROCESS OPTIMIZATION; RADIOCHEMISTRY; RESPONSE SURFACE METHOD; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET WEIGHT; TIME TO RELEASE; XANTHOMONAS; XANTHOMONAS CAMPESTERIS; ANIMAL; CHEMISTRY; CYAMOPSIS; DELAYED RELEASE FORMULATION; HARDNESS; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; RABBIT; STOMACH; TABLET;

ANIMALS; ATENOLOL; BIOPOLYMERS; CHEMISTRY, PHARMACEUTICAL; CYAMOPSIS; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; FEMALE; HARDNESS; MALE; RABBITS; RADIOCHEMISTRY; STOMACH; TABLETS; XANTHOMONAS;

EID: 84894032411     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.01.049     Document Type: Article

References (38)

1. Barrett A.M., Carter J., Fitzgerald J.D., Hull R., Count D. Brazilian Journal of Pharmacology 1973, 48:340-342.
2. Harry J.D., Knapp M.F., Linden R.J. Brazilian Journal of Pharmacology 1974, 51:169-177.
3. Majid P.A., Vander Vijgh W.J.F., De Feijter P.J., Wardeh R., Vander Wall E.E., Ross J.P. European Journal of Cardiology 1979, 9:419-435.
4. Frishman W.H. New England Journal of Medicine 1982, 306:1456-1462.
5. Melander A., Stenberg P., Liedholm H., Schersten B., Wahlin-Boll E. European Journal of Clinical Pharmacology 1979, 16:327-330.
6. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. Pharmaceutical Research 1995, 12:413-420.
7. Dey S., Dutta S., Mazumder B. International Journal of Pharmacy and Pharmaceutical Science 2012, 4:433-437.
8. Kang K., Pettitt D. Industrial Gums: Polysaccharides and Their Derivatives 1993, 341-397. Academic Press, London. R. Whistler, J. Bemiller (Eds.).
9. Remington The Science and Practice of Pharmacy 1995, Mack Publishing Company, Pennsylvania. Nineteenth ed.
10. Dhopeshwarkar V., Zatz J. Drug Development and Industrial Pharmacy 1993, 19:999-1017.
11. Fu L., Woodward L., Borodkin S. Drug Development and Industrial Pharmacy 1991, 17:1987-2004.
12. Khullar P., Khar R.K., Agrawal S.P. Drug Development and Industrial Pharmacy 1998, 24:479-483.
13. Kuhrts E.H., Friend D.R., Parasrampuria K., Yu J. PCT International Application WO96 1996, 16:63-68.
14. Bhalla H.L., Shah A.A. Indian Drugs 1991, 28:420-422.
15. Jain N.K., Kulkarni K., Talwar N. Pharmazie 1992, 47:277-278.
16. Vatsraj N.B., Zia H., Needham T. Formulation and optimization of a sustained release tablet of ketorolac tromethamine. Proceedings of International Symposium on Controlled Release of Bioactive Materials 2000, 8444. Controlled Release Society, Paris.
17. Gohel M.C., Amin A.F. Drug Development and Industrial Pharmacy 1999, 25:247-251.
18. Doornbos D.A., Haan P. Optimization Techniques in Formulation and Processing 1995, 77-160. Marcel Dekker, New York. J. Swarbrick, J.C. Boylan (Eds.).
19. Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical Experimental Design; Drugs and Pharmaceutical Sciences 1999, vol. 92. Marcel Dekker, New York.
20. Singh B., Ahuja N. Book review on pharmaceutical experimental design. International Journal of Pharmaceutics 2000, 195:247-248.
21. Bolton S. Pharmaceutical Statistics: Practical and Clinical Applications 1990, 532-570. Marcel Dekker, New York. 2nd edition.
22. Kettaneh-Wold N. Journal of Pharmaceutical and Biomedical Analysis 1991, 9:605-610.
23. Robinson J.R., Eriksen S.P. Journal of Pharmaceutical Science 1966, 53:1254-1263.
24. Fowler M.B., Brudenell M., Jackson G., Holt D.W. British Journal of Clinical Practice 1984, 38:73-74.
25. Malakar J., Nayak A.K. Chemical Engineering Research and Design 2012, 90:1834-1846.
26. Singh A.V., Nath L.K. Saudi Pharmaceutical Journal 2013, 21:193-200.
27. Shakya R., Thapa P., Saha R.N. Asian Journal of Pharmaceutical Science 2013, 8:191-198.
28. Patel V.F., Patel N.M. AAPS PharmSciTech 2006, 7:E1-E7.
29. Wehrlé P., Nobelis P., Cuiné A., Stamm A. Drug Development and Industrial Pharmacy 1993, 19:1637-1653.
30. Sato Y., Kawashima Y., Takeuchi H., Yamamoto H., Fujibayashi Y. Journal of Controlled Release 2004, 98:75-85.
31. Gupta H., Aqil M., Khar R.K., Ali A., Bhatnagar A., Mittal G., Jain S. AAPS PharmSciTech 2009, 10:540-546.
32. Weiner D.L. Design and Analysis of Bioavailability Studies 1981, 205-229. Marcel Dekker, New York. C.R. Bucncher, J.Y. Tsay (Eds.).
33. Shargel L., Yu A.B.C. Applied Biopharmaceutics and Pharmacokinetics 1993, 47-76. Prentice Hall, New York. 3rd edition.
34. Singh B.M., Kim K.H. Journal of Controlled Release 2000, 63:235-259.
35. Jamzad S., Fassihi R. International Journal of Pharmaceutics 2006, 312:24-32.
36. Tadros M.I. European Journal of Pharmaceutics and Biopharmaceutics 2010, 74:222-229.
37. Krishnaiah Y.S.R., Karthikeyan R.S., Sankar V.G., Satyanarayana V. Journal of Controlled Release 2002, 81:45-56.
38. Velasco M.V., Ford J.L., Rowe P., Rajabi-Siahboomi A.R. Journal of Controlled Release 1999, 57:75-85.